Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 3Stress Disorders, Post-Traumatic 1Motor Activity 1Depression 1Death 1Breast Neoplasms 1Anxiety Disorders 1Advanced Cancer 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Neoplasms × Coping Skills × Clear all
NCT04889755 2025-02-17

R03 CA259898

Boston University Charles River Campus

Phase NA Completed
6 enrolled 22 charts

Neoplasms, Stress Disorders, Post-Traumatic

NCT00740038 2017-02-23

Support for People Undergoing Chemotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
471 enrolled

Motor Activity, Neoplasms

NCT00106067 2015-04-07

A&SC

VA Office of Research and Development

Phase NA Completed
559 enrolled

Death, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡